Details
| Stereochemistry | MIXED |
| Molecular Formula | C18H16Cl2N2O2 |
| Molecular Weight | 363.238 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1COC2(N1CC(=O)NC3=CC=C(Cl)C=C23)C4=C(Cl)C=CC=C4
InChI
InChIKey=ANUCDXCTICZJRH-UHFFFAOYSA-N
InChI=1S/C18H16Cl2N2O2/c1-11-10-24-18(13-4-2-3-5-15(13)20)14-8-12(19)6-7-16(14)21-17(23)9-22(11)18/h2-8,11H,9-10H2,1H3,(H,21,23)
DescriptionCurator's Comment: description was created based on several sources, including
http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1538
Curator's Comment: description was created based on several sources, including
http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1538
Mexazolam (trade names Melex and Sedoxil) is indicated for the management of anxiety with or without psychoneurotic conditions. In adult patients, the recommended daily dosage of mexazolam is 1-3 mg, administered three times daily. Mexazolam is metabolised via the CYP3A4 pathway.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? | 2005 |
|
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
|
| Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis. | 2010 Jun 15 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15489
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
DTXSID9057715
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
SUB08929MIG
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
Mexazolam
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
4526
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
CHEMBL1743261
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
C81637
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
m7515
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | Merck Index | ||
|
31868-18-5
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
1793
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
S5969B6237
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
100000081178
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY | |||
|
4177
Created by
admin on Fri Dec 15 16:11:04 GMT 2023 , Edited by admin on Fri Dec 15 16:11:04 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
